Search Results
Found 1 results
510(k) Data Aggregation
(64 days)
Autoantibodies directed against phospholipids, and anti-cardiolipin (aCL) in particular, have been associated with recurrent thrombosis, thrombocytopenia, and spontaneous abortions. Detection of these autoantibodies may aid in the diagnosis of such disorders. The Zeus Scientific, Inc. Cardiolipin IgA ELISA test system is an enzyme-linked immunosorbent assay (ELISA) designed for the semiquantitative measurement of circulating IgA autoantibodies to cardiolipin. This test is for in vitro diagnostic use.
The Zeus Scientific, Inc. Cardiolipin IgA ELISA test system is an enzyme-linked immunosorbent assay (ELISA) designed for the semiquantitative measurement of circulating IgA autoantibodies to cardiolipin.
The provided text is related to a 510(k) premarket notification for the Zeus Scientific Inc. Anti-Cardiolipin IgA ELISA Reagents. It primarily details the FDA's approval of the device and its intended use. However, it does not contain any information regarding acceptance criteria, device performance studies, sample sizes, expert qualifications, or ground truth establishment relevant to the questions asked.
Therefore, I cannot provide the requested information based on the input text.
Ask a specific question about this device
Page 1 of 1